BCAX earnings
Bicara Therapeutics (BCAX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
BCAX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 9, 2026 | -1.04 | -0.82 | -26.83% | – |
| Q2 2026 | Aug 11, 2026 | -0.82 | -0.82 | -0.03% | – |
| Q1 2026 | May 11, 2026 | -0.93 | -0.64 | -45.31% | – |
| Q4 2025 | Mar 30, 2026 | -0.68 | -0.72 | 5.56% | – |
| Q3 2025 | Nov 10, 2025 | -0.67 | -0.55 | -21.82% | – |
| Q2 2025 | Aug 12, 2025 | -0.50 | -0.54 | 7.41% | – |
| Q1 2025 | May 13, 2025 | -0.68 | -0.40 | -70.00% | – |
| Q4 2024 | Mar 27, 2025 | -0.39 | -0.31 | -25.81% | – |
| Q3 2024 | Nov 12, 2024 | -1.60 | -0.46 | -247.83% | – |
- BCAX beat EPS estimates in 2 of its last 9 reports.
Updated 2026-11-10 04:45 UTC